Professional
Added to YB: 2024-06-07
Pitch date: 2024-06-03
BOUL.ST [bullish]
Boule Diagnostics AB (publ)
-46.27%
current return
Author Info
No bio for this author
Company Info
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East.
Market Cap
SEK 423.3M
Pitch Price
SEK 10.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
8.68
P/E
15.79
EV/Sales
0.97
Sector
Health Care Equipment and Supplies
Category
turnaround
Protean Funds New Position: Boule Diagnostics AB
BOUL.ST: Hematology instrument maker w/ troubled past but bright spots. US reagent biz 2x in 5yrs to 20% sales, vet +60% to near 10%. 32K installed base, 152M annual tests. Q1 SEK19M profit vs SEK400M EV. New Danaher-background CEO may turn around despite near-term risks.
Read full article (1 min)